<DOC>
	<DOC>NCT00092417</DOC>
	<brief_summary>This study compared the safety and tolerability profile of a higher potency investigational vaccine to that of the investigational vaccine at a lower potency dose.</brief_summary>
	<brief_title>Evaluation of the Safety and Tolerability of a Higher Potency Dose of an Investigational Vaccine Among Adults 50 Years of Age and Older (V211-009)</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy individuals 50 years of age or older with a history of chickenpox who have not had herpes zoster Exclusion Criteria : Preexisting conditions that might affect vaccine safety such as conditions that inhibit an immune response</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>